CL
EW icon

Choreo LLC’s Edwards Lifesciences EW Stock Holding History

Choreo LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Buy
17,508
+528
+3% +$43.5K 0.02% 501
2025
Q4 		$1.46M Sell
16,980
-868
-5% -$71.2K 0.02% 466
2025
Q3 		$1.39M Buy
17,848
+1,269
+8% +$99.2K 0.02% 478
2025
Q2 		$1.3M Buy
16,579
+520
+3% +$38.8K 0.02% 495
2025
Q1 		$1.16M Sell
16,059
-1,806
-10% -$129K 0.02% 502
2024
Q4 		$1.33M Sell
17,865
-1,383
-7% -$96.8K 0.02% 468
2024
Q3 		$1.25M Sell
19,248
-5,729
-23% -$416K 0.02% 497
2024
Q2 		$2.26M Buy
24,977
+21,137
+550% +$1.87M 0.04% 292
2024
Q1 		$367K Buy
3,840
+153
+4% +$12.9K 0.01% 480
2023
Q4 		$281K Sell
3,687
-1,050
-22% -$73.1K 0.01% 507
2023
Q3 		$328K Buy
4,737
+470
+11% +$37.8K 0.01% 358
2023
Q2 		$403K Buy
4,267
+22
+0.5% +$1.91K 0.01% 329
2023
Q1 		$351K Buy
4,245
+1,165
+38% +$91.6K 0.01% 361
2022
Q4 		$230K Buy
+3,080
New +$237K 0.01% 210

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Choreo LLC's EW Position: Q1 2026 in Review

Choreo LLC increased its Edwards Lifesciences (EW) stake by 3.1% in Q1 2026, buying an estimated $43.5K and bringing the position to 17,508 shares worth $1.4M. The position accounts for 0.02% of the portfolio, ranked #501.

Choreo LLC first reported a position in EW in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.26M in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Choreo LLC held 17,508 shares of Edwards Lifesciences worth $1.4M as of Q1 2026.
  • Choreo LLC bought 528 Edwards Lifesciences shares in Q1 2026, an estimated $43.5K.
  • Edwards Lifesciences made up 0.02% of Choreo LLC's portfolio in Q1 2026, its #501 holding.
  • Choreo LLC first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 14 quarters since.
  • Choreo LLC's Edwards Lifesciences position peaked at $2.26M in Q2 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.